Drugs / Ginkgo Leaf Tablets
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06813274 Background | Jan → Nov 2026 expected | cognitive disorder, diabetes mellitus, diabetic retinopathy | Hejiang Ye | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo Leaf Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06813274 ↗ |
| Route | Oral | “The prescribed oral dosage is one tablet each time, administered three times a day.” NCT06813274 ↗ |